Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.
No PIIINP Reduction from Spironolactone in Heart Failure Prevention Study
September 17th 2019A proof of concept trial examining spironolactone for heart failure prevention presented at HFSA 2019 found spironolactone use did reduce PIIINP or that its impact on PIIINP was mitigated by galectin-3.
Read More
Dapagliflozin Fast Tracked for Reducing CV Death, Worsening Heart Failure
September 16th 2019Fast Track designation comes about a month after dapagliflozin received another Fast Track designation for delaying the progression of renal failure and prevent CV and renal death in patients with chronic kidney disease
Read More
Discussing Serious Illness Could Cut Costs, Improve End-of-Life Care
September 13th 2019A study from Brigham and Women's Hospital found asking clinicians if they would be surprised if older patients would die in the next month could save patients money on healthcare and improve quality of end-of-life care.
Read More
Leading Healthcare Organizations Urge Congress to Reform Prior Authorizations
September 12th 2019A group of 370 leading healthcare organizations have sent a letter to congress in support of a bipartisan bill that would protect Medicare Advantage Beneficiaries from delays caused by prior authorizations.
Read More